Movano (MOVE) AI Stock Analysis

• Market Cap: $13.51M
• Dividend Yield: N/A
• Average Volume (3M): 27.47K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.51
• Revenue Growth: -44.57%
• EPS Growth: 55.97%
• Country: US
• Employees: 32
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): N/A
• Shares Outstanding: 909,486
• 10 Day Avg. Volume: 32,926
• 30 Day Avg. Volume: 27,469
• PEG Ratio: 3.60
• Price to Book (P/B): 442.23
• Price to Sales (P/S): 3210.86
• P/FCF Ratio: -144.30
• Enterprise Value/Market Cap: 0.59
• Enterprise Value/Revenue: 15.92
• Enterprise Value/Gross Profit: -5.89
• Enterprise Value/Ebitda: -0.52
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 47 Neutral
• Price Target: $13.00 ▲(86.25% Upside)

The score is primarily weighed down by very weak financial performance (heavy losses, negative gross margins, ongoing cash burn, and negative equity). Technicals are a partial offset due to strong momentum above major moving averages, though the very high RSI suggests the move is overextended. Valuation is constrained by negative earnings, and the recent corporate action adds funding flexibility but increases potential dilution risk.

Positive Factors

Low financial leverage

Zero reported debt materially reduces refinancing and interest-rate risk for an early-stage device company. With no scheduled debt service the company has greater flexibility to allocate scarce cash to product development or restructuring, improving survival odds while it pursues scale.

Merger brings scale and capital

The announced merger and accompanying financings create a materially larger combined entity focused on AI infrastructure, providing roughly $40M of new capital and expanded capabilities. This structural change can diversify revenue pools and supply resources to invest in scalable infrastructure and product integration.

Improving cash outflow trend

Operating cash burn materially improved year-over-year, signaling management is reducing operating spend or improving business efficiency. A sustained reduction in cash outflows improves runway and makes future funding needs smaller, a meaningful durable improvement versus prior cash consumption levels.

Negative Factors

Deeply negative gross margins

A gross margin around -270% indicates unit economics currently destroy value: production or cost recognition exceeds product revenue. This structural deficit means scaling sales without fixing costs or pricing will accelerate losses, undermining any pathway to sustainable profitability.

Sustained cash burn & negative equity

Large ongoing cash losses paired with negative shareholders' equity show accumulated deficits have eroded the capital base. This weak balance sheet increases reliance on dilutive financing, constrains strategic choices, and raises the probability of further equity raises to maintain operations.

Major dilution and control shift from merger

The merger results in Corvex owning ~96.2% of the combined company, effectively ceding control and heavily diluting Movano shareholders. While it supplies capital and scale, this structural ownership shift creates governance, integration and strategic-priority risks that can sideline Movano's original business focus.

Movano Business Overview & Revenue Model

Company Description

Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medtech and consumer devices. Its platform uses radiofrequency technology, which enables the creation of sensors that are small enough to fit into wearable devices and other small form factors. The company develops Movano Ring that measures heart rate, heart rate variability, sleep, respiration, temperature, blood oxygen saturation, steps, and calories, as well as incorporates women-centric features and design. It is also developing non-invasive continuous glucose monitoring and cuffless blood pressure monitoring features to its technology platform. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.

How the Company Makes Money

Movano makes money primarily through the sale of its wearable healthcare devices. The company's revenue model revolves around direct sales to consumers, partnerships with healthcare providers, and potentially through subscription-based services that offer enhanced features or data analytics. Movano may also explore partnerships with insurance companies or corporate wellness programs, leveraging its technology to offer value-added services. Additionally, Movano could generate revenue from licensing its technology to other companies in the healthcare and technology sectors. These revenue streams are supported by ongoing research and development, aimed at expanding the capabilities and market reach of its products.

Movano Financial Statement Overview

Summary

Fundamentals are very weak: modest TTM revenue (~$0.5M) with deeply negative gross margin (~-270%), extremely negative net margin (~-1,568%), and significant ongoing cash burn (TTM operating cash flow ~-$13.6M). While debt is low (zero debt shown), negative stockholders’ equity (~-$1.7M) increases balance-sheet risk and highlights continued dependence on external funding.

Income Statement

MOVE is still in a heavy loss-making phase. In TTM (Trailing-Twelve-Months), revenue is modest ($0.5M) despite strong percentage growth, while gross profit remains deeply negative (gross margin about -270%), indicating the company is not yet covering core product and operating costs. Profitability is very weak with a net margin around -1,568% and EBIT also sharply negative, although net losses improved versus 2024 on an absolute-dollar basis.

Balance Sheet

Leverage is currently low (TTM shows zero debt), which reduces financial risk from interest and refinancing. However, the balance sheet has weakened materially as stockholders’ equity is now negative in TTM (about -$1.7M), signaling accumulated losses have eroded the capital base; returns on equity are also strongly negative. Assets have also declined versus prior years, limiting flexibility if additional funding is needed.

Cash Flow

Cash burn remains significant, with TTM operating cash flow around -$13.6M and free cash flow roughly the same, indicating the business is still funding operating losses with external capital. The cash outflow improved versus 2024 (operating cash flow moved from about -$22.5M to -$13.6M), but free cash flow growth is negative and the company is not yet demonstrating self-funding operations.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	500.00K	1.01M	0.00	0.00	0.00	0.00
Gross Profit	-1.35M	-1.99M	-158.00K	-134.00K	-74.00K	-13.00K
EBITDA	-15.45M	-24.06M	-29.13M	-30.20M	-20.82M	-12.01M
Net Income	-17.05M	-23.73M	-29.28M	-30.20M	-22.58M	-14.04M
Balance Sheet
Total Assets	5.56M	11.32M	9.42M	13.24M	36.27M	7.08M
Cash, Cash Equivalents and Short-Term Investments	2.00M	7.90M	6.12M	10.76M	33.60M	5.71M
Total Debt	0.00	186.00K	217.00K	426.00K	0.00	11.69M
Total Liabilities	7.26M	3.96M	5.97M	5.33M	3.54M	15.14M
Stockholders Equity	-1.70M	7.36M	3.45M	7.92M	32.73M	-8.06M
Cash Flow
Free Cash Flow	-13.57M	-22.54M	-26.24M	-25.01M	-16.75M	-10.67M
Operating Cash Flow	-13.56M	-22.53M	-26.18M	-24.90M	-16.18M	-10.67M
Investing Cash Flow	-5.00K	-8.00K	-64.00K	15.72M	-16.70M	0.00
Financing Cash Flow	4.30M	24.32M	21.60M	2.26M	44.85M	12.09M

Movano Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 6.98
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MOVE, the sentiment is Positive. The current price of 6.98 is below the 20-day moving average (MA) of 11.28, below the 50-day MA of 9.85, and below the 200-day MA of 7.94, indicating a bullish trend. The MACD of 2.23 indicates Negative momentum. The RSI at 53.54 is Neutral, neither overbought nor oversold. The STOCH value of 29.35 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MOVE.

Movano Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
MOVE	47 Neutral	$13.51M	-0.57	-398.78%	―	-44.57%	55.97%
BJDX	46 Neutral	$2.39M	-0.02	-126.20%	―	―	97.70%
TIVC	45 Neutral	$2.78M	-0.11	-178.18%	―	-49.63%	82.22%
AMIX	40 Underperform	$2.80M	-0.08	-352.39%	―	―	63.87%

Movano Corporate Events

Movano Stockholders Approve Key Amendments and Initiatives

On December 16, 2025, Movano Inc.’s stockholders approved key amendments and initiatives during a Special Meeting, including Amendment No. 3 to its 2019 Omnibus Incentive Plan, enhancing the ability to further incentivize employees. Additionally, stockholders endorsed increasing the company’s authorized shares of common stock from 500 million to 2.5 billion, paving the way for potential expansion and fundraising opportunities, while also aligning with Nasdaq compliance for a share issuance agreement.

The most recent analyst rating on (MOVE) stock is a Buy with a $30.00 price target. To see the full list of analyst forecasts on Movano stock, see the MOVE Stock Forecast page.

Movano Announces Merger with Corvex, Inc.

On November 6, 2025, Movano Inc. entered into a merger agreement with Corvex, Inc., where Corvex will become a wholly-owned subsidiary of Movano. The merger, expected to close in the first quarter of 2026, aims to position the combined company to capture demand for AI infrastructure at scale. Corvex stockholders will own approximately 96.2% of the combined entity, with Movano stockholders owning 3.8%. The merger includes significant equity financing, with Movano raising $3 million and Corvex raising $37.1 million. The merger will also see Movano’s name change to Corvex, Inc., and its headquarters move to Arlington, Virginia.

The most recent analyst rating on (MOVE) stock is a Buy with a $30.00 price target. To see the full list of analyst forecasts on Movano stock, see the MOVE Stock Forecast page.

Movano Amends Loan Agreement with Evie Holdings

Movano announced an amendment to its existing Loan Agreement with Evie Holdings LLC, originally dated August 6, 2025. The amendment, entered on November 3, 2025, extends the maturity date of the loan to November 5, 2025, providing the company with additional time to manage its financial obligations.

The most recent analyst rating on (MOVE) stock is a Buy with a $30.00 price target. To see the full list of analyst forecasts on Movano stock, see the MOVE Stock Forecast page.